Identification of Some Issues and Questions to be Answered in Comparing Type I and Type II Diabetes

  • Mladen Vranic
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 189)


This chapter will attempt to identify some of the issues and questions arising from the present classification of and comparisons between Type I and Type II diabetes. Because these issues will also be dealt with in other chapters of this book in depth, it was not considered necessary to include herein a complete list of references.


Insulin Resistance Insulin Secretion Gestational Diabetes Glucose Intolerance Glucose Utilization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes 28, 1039–1057 (1979).Google Scholar
  2. 2.
    S.C. Sushruta, “Vaidya Jadavaji Trikamji Acharia,” Nirnyar Sasar Press, Bombay (1938) (The original book was published in 500 B.C).Google Scholar
  3. 3.
    P. Zimmet, Epidemiology of diabetes mellitus, in: “Diabetes Mellitus - Theory and Practice,” M. Ellenberg and H. Rifkin, eds., Medical Examination Pub. Co. Inc., New York (1983).Google Scholar
  4. 4.
    P. Bennett, Basis of the present classification of diabetes, in: “Comparison of Type I and Type II Diabetes” (1985).Google Scholar
  5. 5.
    H. Keen, Limitations of the present classification of diabetes from an epidemiological point of view, Ibid (1985).Google Scholar
  6. 6.
    N. Freinkel and B.E. Metzger, Gestational diabetes: Problems in classification and implications for long range prognosis, Ibid (1985).Google Scholar
  7. 7.
    S.S. Fajans, Heterogeneity within type II and MODY diabetes, Ibid (1985).Google Scholar
  8. 8.
    K.A. Permutt, Genetics of type I and type II diabetes. Analysis by recombinant DNA methods, Ibid (1985).Google Scholar
  9. 9.
    A. Lernmark, Immunological aspects of etiology and pathogenesis of type I and type II diabetes, Ibid. (1985).Google Scholar
  10. 10.
    S. Efendic, R. Luft and A. Wajngot, Endocrine Reviews 5: 95–410 (1984).CrossRefGoogle Scholar
  11. 11.
    S.W. Shen, G.H. Reaven, and J.W. Farquhar, J. Clin. Invest. 49: 2151 (1970).PubMedCrossRefGoogle Scholar
  12. 12.
    R.A. DeFronzo, J.D. Tobin, and R. Andres, Am. J. Physiol. 237: E214 (1979).PubMedGoogle Scholar
  13. 13.
    O.G. Kolterman, L.J. Insel, M. Sackow, and J.M. Olefsky, J. Clin. Invst. 65: 1272 (1980).CrossRefGoogle Scholar
  14. 14.
    C.R. Kahn, “Metabolism,” 27: 1893 (1978).Google Scholar
  15. 15.
    E. Cerasi, and R. Luft, Acta Endocriol (Copenh) 55: 278: 304 (1967).Google Scholar
  16. 16.
    E. Cerasi, Acta Endocrinol (Copenh) 55: 163 (1967).Google Scholar
  17. 17.
    E. Cerasi, R. Luft, Diabetes 16: 615: 627 (1967).Google Scholar
  18. 18.
    R.N. Bergman, Y.Z. Ider, C.R. Bowden, and C. Cobelli, Am. J. Physiol. 236: E667 (1979).PubMedGoogle Scholar
  19. 19.
    D.T. Finegood, G. Pacini, and R.N. Bergman, Diabetes 33: 362 (1984).PubMedCrossRefGoogle Scholar
  20. 20.
    R.C. De Bodo, R. Steele, N. Altszuler, A. Dunn, and J.S. Bishop, Recent Prog. Horm. Res. 19: 445–488 (1963).Google Scholar
  21. 21.
    J.S. Cowan and G. Hetenyi, Metabolism 20: 360–373 (1971).PubMedCrossRefGoogle Scholar
  22. 22.
    J. Radziuk, K.H. Norwich, and M. Vranic, Am. J. Physiol. 234: E84–93 (1978).PubMedGoogle Scholar
  23. 23.
    G. Reaven, Insulin stimulated glucose disposal in patients with type I (IDDM) and type II (NIDDM) diabetes mellitus, in: “Comparison of Type I and Type II Diabetes,” Plenum Press (1985).Google Scholar
  24. 24.
    W.K. Ward, J.C. Beard, J.B. Halter, and D. Porte, Pathophysiology in insulin secretion in diabetes mellitus, Ibid. (1985).Google Scholar
  25. 25.
    B. Posner, M.N. Kahn, and J.J.H. Bergeron, Internalization of insulin structure involved and their significance, Ibid (1985).Google Scholar
  26. 26.
    J.M. Olefsky, R.R. Revers, M. Prince, R. Henry, W.T. Garvey, J.A. Scarlett, and 0.G. Kolterman, Insulin resistance in non insulin dependent (type II) and insulin dependent (type I) diabetes mellitus, Ibid (1985).Google Scholar
  27. 27.
    M. Vranic, A. Wajngot, and S. Efendic, New probes to study insulin resistance in men: futile cycle and glucose turnover, Ibid. (1985).Google Scholar
  28. 28.
    M. Vranic, S. Morita, and G. Steiner, Diabetes 29: 169–176 (1980).PubMedCrossRefGoogle Scholar
  29. 29.
    G. Steiner, S. Morita, and M. Vranic, Diabetes 29: 889–905 (1980).CrossRefGoogle Scholar
  30. 30.
    J. Radziuk, T.J. McDonald, D. Rubenstein, and J. Dupre, Metabolism 28: 300–307 (1979).PubMedCrossRefGoogle Scholar
  31. 31.
    S. Efendic, A. Wajngot, and M. Vranic, Proc. Natl. Acad. Sci. U.S.A. (1985, in press).Google Scholar
  32. 32.
    S. Karlander, A. Roovete, A. Vajngot, M. Vranic, and S. Efendic, Diabetologia 27:294A. Abstract 260 (1984).Google Scholar
  33. 33.
    A. Wajngot, A. Roovete, M. Vranic, R. Luft, and S. Efendic, Proc. Natl. Acad. Sci, USA 79: 4432–4436 (1982).CrossRefGoogle Scholar
  34. 34.
    G. Hetenyi Jr., Can. J. Physiol, Pharmacol 57: 767–770 (1979).CrossRefGoogle Scholar
  35. 35.
    J. Dupre, A. Baer, M. Lee, J.T. McDonald, J. Radziuk, N.W. Rodger, and S. Sullivan, Insulin mediated and non-insulin mediated effects of gastroentoeropancreatic peptides in type I and type II diabetes, in: “Comparison of Type I and Type II Diabetes,” Plenum Press (1985).Google Scholar
  36. 36.
    J. Radziuk, and T. Morishima, New methods for the analysis of insulin kinetics in vivo, Ibid (1985).Google Scholar
  37. 37.
    M. Berger, P.A. Halban, W.A. Muller, R.E. Offord, A.E. Renold and M. Vranic, Diabetologia 15: 133–140 (1978).PubMedCrossRefGoogle Scholar
  38. 38.
    M. Vranic, F.W. Kemmer, P. Berchtold, and M. Berger, Hormonal intereactions in control of metabolism during exercise in physiology and diabetes, in: “Diabetes Mellitis - Theory and Practice,” M. Ellenberg, and H. Rifkin, eds., Medical Examination Pub. Co. Inc., New York (1983).Google Scholar
  39. 39.
    M. Vranic, and L. Lickley, Exercise and stress in Diabetes Mellitus, in: “Clinical Diabetes Mellitus,” J.K. Davidson, ed., Thieme-Stratton Inc. (In press) Ch. 15. (1985).Google Scholar
  40. 40.
    G. Perez, F.W. Kemmer, H.L.A. Lickley, and M. Vranic, Am. J. Physiol 241: E328–335 (1981).PubMedGoogle Scholar
  41. 41.
    J.E. Gerich, V. Schneider, S.E. Dippe, M. Longlois, C. Nuacco, J.H. Karam and P.H. Forsham, Science 182: 171–173 (1973).PubMedCrossRefGoogle Scholar
  42. 42.
    T.D. Maher, R.J. Tannenberg, B.Z. Greenberg, J.E. Hoffman, R.P. Doe, and F.C. Goetz, J. Clin. Endocrionol. Metab. 44: 459–464 (1977).CrossRefGoogle Scholar
  43. 43.
    J. Hilsted, S. Marsbad, T. Krazup, L. Sestoft, N.J. Christensen, B. Tronier, and H. Galbo, Diabetes 30: 626–632 (1983).Google Scholar
  44. 44.
    G. Bolli, P. DeFeo, P. Compagnucci, M. Castechini, G. Angeletti, F. Santeusanio, P. Brunetti, and J.E. Gerich, Diabetes 32: 134–141 (1983).PubMedCrossRefGoogle Scholar
  45. 45.
    P.E. Cryer, and J.G. Gerich, Diabetes Care 6: 95–99 (1983).PubMedCrossRefGoogle Scholar
  46. 46.
    R.H. Unger, and L. Orci, “Glucagon Physiology, Pathophysiology and Morphology of the Pancreatic A Cell,” Esevier, New York (1981).Google Scholar
  47. 47.
    V. Schusdziarra, D. Rouiller, V. Harris, J.M. Coulon, and R.H. Unger, Endocrinology 103: 2264 (1978).PubMedCrossRefGoogle Scholar
  48. 48.
    V. Grill, M. Gutniak, A. Roovete, and S. Efendic, J. Clin. Endocrinol. (In press) (1984).Google Scholar
  49. 49.
    E. Ipp, R.E. Dobbs, and R.H. Unger, Nature 276: 190–191 (1981).CrossRefGoogle Scholar
  50. 50.
    K. El Tayebn, P. Brubaker, L. Lickley, and M. Vranic, The International Congress of Endocrinology, Excerpta Medica International Congress Series 652:477, Abstract #434 (1984).Google Scholar
  51. 51.
    K. El Tayeb, P. Brubaker, L. Lickley, and M. Vranic, Diabetes 33, Suppl. 1, 51a. Abstract #202 (1984).Google Scholar
  52. 52.
    M. Vranic, R. Kawamori, S. Pek, N. Kovacevic, and G.A. Wrenshall, J. Clin. Invest. 57: 245–255 (1975).CrossRefGoogle Scholar
  53. 53.
    R. Kawamori, and M. Vranic, J. Clin. Invest. 59: 331–337 (1977).PubMedCrossRefGoogle Scholar
  54. 54.
    B. Zinman, F.T. Murray, M. Vranic, A.H. Albisser, B.S. Leibel, P.A. McClean, and E. Marliss, J. Clin. Endocrinol. Metab. 45: 641–652 (1977).CrossRefGoogle Scholar
  55. 55.
    H.L. Minuk, M. Vranic, E.B. Marliss, A.K. Hanna, A.M. Albisser and B. Zinman, Am. J. Physiol. 240: E458–464 (1981).PubMedGoogle Scholar
  56. 56.
    G. Steiner, Atherosclerosis, the major complication of diabetes, in: “Comparison of Type I and Type II Diabetes,” Plenum Press (1985).Google Scholar
  57. 57.
    S.M. Mauer, B.M. Chavers, A comparison of kidney disease in type I and type II diabetes, Ibid (1985).Google Scholar
  58. 58.
    J. Dick, A. Windebank, H. Yasuda, J. Service, R. Rizza, and B. Zimmerman, Functional and pathological alterations in human diabetic nephropathy, Ibid. (1985).Google Scholar
  59. 59.
    R. Klein, H.D. Davis, S.E. Moss, E.K.B. Klein, and D.L. de Mets, The Wisconsin Epidemiological study of diabetic neuropathy, Ibid. (1985).Google Scholar
  60. 60.
    G. Cahill, Some summarizing thoughts. Ibid. (1985).Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Mladen Vranic
    • 1
  1. 1.Department of Physiology & MedicineUniversity of TorontoTorontoCanada

Personalised recommendations